Gastrointestinal Medications
Acid-related and motility disorders include gastro-oesophageal reflux, peptic ulcer disease and dyspepsia. Treatment is led by a clinician and may include proton pump inhibitors, H2-blockers, antacids and Helicobacter pylori eradication regimens.
Overview
Acid-related disorders include gastro-oesophageal reflux disease (GORD), peptic ulcer disease, functional dyspepsia and erosive oesophagitis. Symptoms typically include heartburn, regurgitation, epigastric pain, nausea or, in advanced cases, dysphagia. Helicobacter pylori infection is a major contributor to peptic ulcer disease and certain gastric cancers. According to international epidemiological surveys, GORD affects approximately 10% to 30% of adults in many regions. Diagnosis combines clinical assessment with endoscopy and pH-testing in selected cases.
Common treatments
Pharmacological options include proton pump inhibitors (PPIs) such as omeprazole, esomeprazole and pantoprazole, H2-receptor antagonists such as famotidine, antacids and alginates for episodic relief, prokinetics in selected cases and Helicobacter pylori eradication therapy combining antibiotics with a PPI. Antiemetics, antidiarrhoeals and laxatives are used for related gastrointestinal complaints. According to clinical guidelines, lifestyle measures such as weight management, raised head of bed and avoidance of late meals are important adjuncts.
When to consult
A medical evaluation is recommended whenever upper gastrointestinal symptoms persist for more than several weeks or recur frequently, especially in adults over 55, with weight loss, dysphagia, vomiting or anaemia. Acute severe abdominal pain, haematemesis or melena require emergency care. According to clinical guidelines, the first consultation should explore symptom pattern, lifestyle factors, current medications including NSAIDs and family history. Self-medication with online prescription PPIs is discouraged because it bypasses diagnostic assessment.
Medications
Frequently asked questions
How is GORD different from occasional heartburn? ▾
Occasional heartburn after large meals or specific foods is common and often responds to lifestyle measures and antacids. Gastro-oesophageal reflux disease (GORD) is defined by frequent or troublesome reflux symptoms, with or without endoscopic evidence of mucosal damage, that affect quality of life or lead to complications. According to clinical guidelines, persistent symptoms several times a week warrant medical assessment, particularly if alarm features are present.
Can PPIs be taken long-term? ▾
Proton pump inhibitors are commonly used for prolonged periods in chronic GORD, Barrett's oesophagus and peptic ulcer prophylaxis with NSAIDs. Long-term use has been associated with potential reductions in vitamin B12 and magnesium absorption, an increased risk of bone fractures and possible enteric infections. According to international guidelines, long-term PPI therapy should be regularly reassessed, with the lowest effective dose used.
What is Helicobacter pylori eradication therapy? ▾
Helicobacter pylori is a bacterium that infects the stomach and contributes to peptic ulcer disease and gastric cancer. Eradication therapy combines a proton pump inhibitor with two or more antibiotics for 10 to 14 days, with the regimen guided by local resistance patterns. According to international guidelines, confirmation of eradication after treatment is recommended, typically with urea breath testing or stool antigen testing.
Are H2-blockers still used? ▾
Yes, although less frequently than PPIs for chronic GORD. H2-receptor antagonists such as famotidine block histamine-stimulated gastric acid secretion and remain useful for episodic heartburn, nocturnal symptoms in patients on PPIs and selected acute scenarios. According to the prescribing information, ranitidine has been withdrawn from many markets because of nitrosamine contamination, while famotidine remains widely available.
Is online purchase of acid-suppression medication safe? ▾
Buying prescription proton pump inhibitors and H2-blockers from unverified online sources is associated with documented risks: counterfeit tablets, incorrect strengths, undeclared ingredients and absence of medical review. This is particularly relevant when alarm symptoms are present and require endoscopic investigation. Regulatory bodies recommend purchasing only from licensed pharmacies and only after evaluation by a qualified clinician.
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.